Currently out of the existing stock ratings of Timur Ivannikov, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Timur Ivannikov

Work Performance Price Targets & Ratings Chart

Analyst Timur Ivannikov, currently employed at RAYMOND JAMES, has had 25% of price targets met with an average potential upside of 16.03%, reached in 80 days on average.

Timur Ivannikov has documented 10 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 05-May-2023.

Wall Street Analyst Timur Ivannikov

Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) on 7/8/2022. The price target of $22 was fulfilled within 159 days with a profit of $5.34 (32.05%), with a performance score of 2.02.

Average potential price target upside

NEXI Neximmune RCKT Rocket Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$7.5

4 years 6 days ago
(16-Nov-2022)

1/1 (100%)

$-5.25 (-41.18%)

29

Hold

4 years 7 days ago
(15-Nov-2022)

0/2 (0%)

$271.75 (107.31%)

Buy

$50

$175

4 years 3 months 6 days ago
(16-Aug-2022)

0/2 (0%)

$19.25 (62.60%)

Show more analysts

Stocks Timur Ivannikov covered previously. Scores are shown for active stocks only.

ANAB AnaptysBio CBIO Catalyst Biosciences KYMR Kymera Therapeutics LPTX Leap Therapeutics NE Noble plc

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Timur Ivannikov?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?